United States Peripheral Arterial Disease (PAD) Therapeutics Market Report 2017

Publisher Name :
Date: 02-Jan-2018
No. of pages: 107
Inquire Before Buying

In this report, the United States Peripheral Arterial Disease (PAD) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Peripheral Arterial Disease (PAD) Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Peripheral Arterial Disease (PAD) Therapeutics market competition by top manufacturers/players, with Peripheral Arterial Disease (PAD) Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- AstraZeneca Plc. (UK)

- Bayer HealthCare Pharmaceuticals (Germany)

- Bristol-Myers Squibb Company (US)

- Merck & Co., Inc. (US)

- Proteon Therapeutics, Inc. (US)

- Sanofi S.A. (France)

- Symic Bio, Inc. (US)

- TheraVasc Inc. (US)

- AnGes MG, Inc. (Japan)

- Athersys, Inc. (US)

- Betagenon AB (Sweden)

- miRagen Therapeutics, Inc. (US)

- Multi Gene Vascular Systems Ltd (Israel)

- ViroMed Co. Ltd. (Korea)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Anti-Platelet Drugs

- Dual Antiplatelet Therapy Drugs

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospitals

- Clinics

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Peripheral Arterial Disease (PAD) Therapeutics Market Report 2017

Table of Contents
United States Peripheral Arterial Disease (PAD) Therapeutics Market Report 2017
1 Peripheral Arterial Disease (PAD) Therapeutics Overview
1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Classification of Peripheral Arterial Disease (PAD) Therapeutics by Product Category
1.2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Anti-Platelet Drugs
1.2.4 Dual Antiplatelet Therapy Drugs
1.2.5 Others
1.3 United States Peripheral Arterial Disease (PAD) Therapeutics Market by Application/End Users
1.3.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 United States Peripheral Arterial Disease (PAD) Therapeutics Market by Region
1.4.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.4.3 Southwest Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.4.5 New England Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.4.6 The South Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.4.7 The Midwest Peripheral Arterial Disease (PAD) Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Peripheral Arterial Disease (PAD) Therapeutics (2012-2022)
1.5.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2012-2022)
2 United States Peripheral Arterial Disease (PAD) Therapeutics Market Competition by Players/Suppliers
2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Peripheral Arterial Disease (PAD) Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
2.4.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
2.4.2 United States Peripheral Arterial Disease (PAD) Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
3 United States Peripheral Arterial Disease (PAD) Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Peripheral Arterial Disease (PAD) Therapeutics Price by Region (2012-2017)
4 United States Peripheral Arterial Disease (PAD) Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2012-2017)
4.4 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Type (2012-2017)
5 United States Peripheral Arterial Disease (PAD) Therapeutics Sales (Volume) by Application (2012-2017)
5.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Peripheral Arterial Disease (PAD) Therapeutics Players/Suppliers Profiles and Sales Data
6.1 AstraZeneca Plc. (UK)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bayer HealthCare Pharmaceuticals (Germany)
6.2.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb Company (US)
6.3.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck & Co., Inc. (US)
6.4.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Proteon Therapeutics, Inc. (US)
6.5.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi S.A. (France)
6.6.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Symic Bio, Inc. (US)
6.7.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 TheraVasc Inc. (US)
6.8.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 AnGes MG, Inc. (Japan)
6.9.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Athersys, Inc. (US)
6.10.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Betagenon AB (Sweden)
6.12 miRagen Therapeutics, Inc. (US)
6.13 Multi Gene Vascular Systems Ltd (Israel)
6.14 ViroMed Co. Ltd. (Korea)
7 Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Cost Analysis
7.1 Peripheral Arterial Disease (PAD) Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (K Units) by Type (2012-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-Platelet Drugs Product Picture
Figure Dual Antiplatelet Therapy Drugs Product Picture
Figure Others Product Picture
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Players/Suppliers
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Players/Suppliers
Table United States Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Peripheral Arterial Disease (PAD) Therapeutics Product Category
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Region (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Region (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Region (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2016
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Region (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Region in 2016
Table United States Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Region (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Type (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Type (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type in 2016
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2016
Table United States Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Types (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application (2012-2017)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2016
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Proteon Therapeutics, Inc. (US) Basic Information List
Table Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Symic Bio, Inc. (US) Basic Information List
Table Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table TheraVasc Inc. (US) Basic Information List
Table TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table AnGes MG, Inc. (Japan) Basic Information List
Table AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Athersys, Inc. (US) Basic Information List
Table Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate (2012-2017)
Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share in United States (2012-2017)
Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share in United States (2012-2017)
Table Betagenon AB (Sweden) Basic Information List
Table miRagen Therapeutics, Inc. (US) Basic Information List
Table Multi Gene Vascular Systems Ltd (Israel) Basic Information List
Table ViroMed Co. Ltd. (Korea) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peripheral Arterial Disease (PAD) Therapeutics
Figure Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics
Figure Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Peripheral Arterial Disease (PAD) Therapeutics
Table Distributors/Traders List
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Type in 2022
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Application in 2022
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • EMEA (Europe, Middle East and Africa) Antivenom Market 2017 Forecast to 2022
    Published: 22-Feb-2018        Price: US 4480 Onwards        Pages: 118
    Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection. Scope of the Report: This report focuses on the Antivenom in EMEA market, covering Europe, Middle East and Africa, This repor......
  • EMEA (Europe, Middle East and Africa) Blood Banking Market 2017 Forecast to 2022
    Published: 22-Feb-2018        Price: US 4480 Onwards        Pages: 116
    This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes ref......
  • EMEA (Europe, Middle East and Africa) Closed System Transfer Device (CSTD) Market 2017 Forecast to 2022
    Published: 22-Feb-2018        Price: US 4480 Onwards        Pages: 121
    Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. Scope of the Report: This report focuses on the Closed System Transfer Device (CSTD) in EMEA market, covering Europe, Middl......
  • EMEA (Europe, Middle East and Africa) Neurological Biomarkers Market 2017 Forecast to 2022
    Published: 22-Feb-2018        Price: US 4480 Onwards        Pages: 115
    A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. In the era of molecular medicine, biomarkers usually mean molecular biomarkers and can be divided into 3 broad categories Scope of the Report: This repor......
  • United States Embolization Particle Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 21-Feb-2018        Price: US 4480 Onwards        Pages: 118
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in United States market, to spli......
  • United States Eye Anatomical Model Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 21-Feb-2018        Price: US 4480 Onwards        Pages: 121
    Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models Scope of the Report: This report focuses on the Eye Anatomical Model in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this ......
  • United States HbA1c Testing Device Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 21-Feb-2018        Price: US 4480 Onwards        Pages: 116
    HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. Scope of the Report: This report focuses on the HbA1c Testing Device in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers - Abbott Laboratories - Roche - Siemens......
  • United States Helicobacter Pylori Testing Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 21-Feb-2018        Price: US 4480 Onwards        Pages: 124
    This report studies the Helicobacter Pylori Testing market, Helicobacter pylori testing is used to diagnose an infection due to the bacteria and to evaluate the effectiveness of treatment. Scope of the Report: This report focuses on the Helicobacter Pylori Testing in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers - Sekisui Diagnostics - F. Hoffma......
  • Global Female Contraceptive Market 2018-2022
    Published: 20-Feb-2018        Price: US 3500 Onwards        Pages: 136
    About Female Contraceptive Female contraceptives are used by women for family planning and to avoid unintended pregnancies. The analysts forecast global female contraceptive market to grow at a CAGR of 3.44 % during the period 2018-2022. Covered in this report This report covers the present scenario and the growth prospects of the global female contraceptive market for 2018-2022. To calculate the market size, the report considers the revenue ge......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs